CEO of Sanaria, Dr. Stephen L. Hoffman, to present at the World Vaccine Congress on April 20th, 2022
On April 20th, 2022, Dr. Stephen L. Hoffman will present during the 2022 World Vaccine Congress on malaria clinical trials. His talk will be focused on human monoclonal antibodies development to prevent malaria as well as engineering malaria sporozoites as carriers of foreign molecules to immunize against five separate infectious diseases
Please visit this link to register and access additional information.
